William L. Macias - Concepedia

Author

William L. Macias

Also Known As

Raul Lombardi, W L Macias, W Macias, W. L. Macias, W. Macias, W.L. Macias, WILLIAM L. MACIAS, William L Macias, William L. MacIas, William L. Macias

125

Publications

14.8K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Indiana University – Purdue University Indianapolis Indiana University School of Medicine Baxter (United States)Stanford University

About

William L. Macias is an author at Eli Lilly (United States) specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	2.1K
2	Health Sciences	1	1	83
3	Allergy	1	1	83
4	Biochemistry	1	1	62
5	Cellular Physiology	1	1	24

William L. Macias

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Cytochrome P-450 Polymorphisms and Response to Clopidogrel Jessica L. Mega, Sandra Close, Stephen D. Wiviott, New England Journal of Medicine	2008	2.4K
Drotrecogin Alfa (Activated) in Adults with Septic Shock V. Marco Ranieri, Bruce Thompson, Philip S. Barie, New England Journal of Medicine	2012	1.3K
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis Peter C. Taylor, Edward Keystone, Désirée van der Heijde, New England Journal of Medicine	2017	895
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death Edward Abraham, Pierre‐François Laterre, Rekha Garg, New England Journal of Medicine	2005	882
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Jessica L. Mega, Sandra Close, Stephen D. Wiviott, Circulation	2009	648
Baricitinib in Patients with Refractory Rheumatoid Arthritis Mark C. Genovese, Joel Kremer, Omid Zamani, New England Journal of Medicine	2016	598
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial Simon Nadel, Brahm Goldstein, Mark D. Williams, The Lancet Severe SepsisPediatricsSepsisSepsis PhenotypingMulticentre Phase Iii	2007	499
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies Gina A. Montealegre Sanchez, Adam Reinhardt, Suzanne Ramsey, Journal of Clinical Investigation	2018	496
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment Roy Fleischmann, Michael Schiff, Désirée van der Heijde, Arthritis & Rheumatology	2016	396
Early changes in organ function predict eventual survival in severe sepsis* Mitchell M. Levy, William L. Macias, Jean‐Louis Vincent, Critical Care Medicine	2005	357

Page 1